Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

A National Survey of Medical Oncologist's Opinions and Perceptions for Managing Rash Among mCRC Patients Treated with Panitumumab.

Lowe KA, Sangaré L, Bergstresser R, McNamara M, Kafatos G, Garawin T.

Dermatol Ther (Heidelb). 2019 Jun;9(2):337-353. doi: 10.1007/s13555-019-0296-z. Epub 2019 May 3.

2.

Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With Panitumumab.

Lowe KA, Sangaré L, Roehl KA, Jung S, Kafatos G, Garwin T.

Clin J Oncol Nurs. 2019 Apr 1;23(2):157-164. doi: 10.1188/19.CJON.157-164.

PMID:
30880806
3.

Functional Categories of Visuomotor Neurons in Macaque Frontal Eye Field.

Lowe KA, Schall JD.

eNeuro. 2018 Oct 17;5(5). pii: ENEURO.0131-18.2018. doi: 10.1523/ENEURO.0131-18.2018. eCollection 2018 Sep-Oct.

4.

Prefrontal Control of Visual Distraction.

Cosman JD, Lowe KA, Zinke W, Woodman GF, Schall JD.

Curr Biol. 2018 Apr 23;28(8):1330. doi: 10.1016/j.cub.2018.03.061. No abstract available.

5.

Prefrontal Control of Visual Distraction.

Cosman JD, Lowe KA, Zinke W, Woodman GF, Schall JD.

Curr Biol. 2018 Feb 5;28(3):414-420.e3. doi: 10.1016/j.cub.2017.12.023. Epub 2018 Jan 18. Erratum in: Curr Biol. 2018 Apr 23;28(8):1330.

6.

Never too old: late-onset Leber hereditary optic neuropathy.

Vincent SJ, Lowe KA, Monsour CS.

Clin Exp Optom. 2018 Jan;101(1):137-139. doi: 10.1111/cxo.12530. Epub 2017 Mar 9. No abstract available.

PMID:
28281297
7.

Temporal Dynamics of In-Field Bioreactor Populations Reflect the Groundwater System and Respond Predictably to Perturbation.

King AJ, Preheim SP, Bailey KL, Robeson MS 2nd, Roy Chowdhury T, Crable BR, Hurt RA Jr, Mehlhorn T, Lowe KA, Phelps TJ, Palumbo AV, Brandt CC, Brown SD, Podar M, Zhang P, Lancaster WA, Poole F, Watson DB, W Fields M, Chandonia JM, Alm EJ, Zhou J, Adams MW, Hazen TC, Arkin AP, Elias DA.

Environ Sci Technol. 2017 Mar 7;51(5):2879-2889. doi: 10.1021/acs.est.6b04751. Epub 2017 Feb 10.

8.

Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States.

Lowe KA, Danese MD, Gleeson ML, Langeberg WJ, Ke J, Kelsh MA.

J Gastrointest Cancer. 2016 Jun;47(2):168-81. doi: 10.1007/s12029-016-9809-5.

PMID:
26961791
9.

Navigating the profits and pitfalls of governmental partnerships: the ICRC and intergovernmental relief, 1918-23.

Lowe KA.

Disasters. 2015 Oct;39 Suppl 2:204-18. doi: 10.1111/disa.12154.

PMID:
26395109
10.

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ.

Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19.

PMID:
26292694
11.

Natural bacterial communities serve as quantitative geochemical biosensors.

Smith MB, Rocha AM, Smillie CS, Olesen SW, Paradis C, Wu L, Campbell JH, Fortney JL, Mehlhorn TL, Lowe KA, Earles JE, Phillips J, Techtmann SM, Joyner DC, Elias DA, Bailey KL, Hurt RA Jr, Preheim SP, Sanders MC, Yang J, Mueller MA, Brooks S, Watson DB, Zhang P, He Z, Dubinsky EA, Adams PD, Arkin AP, Fields MW, Zhou J, Alm EJ, Hazen TC.

MBio. 2015 May 12;6(3):e00326-15. doi: 10.1128/mBio.00326-15.

12.

Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study.

St Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ.

BMC Nephrol. 2015 Mar 31;16:41. doi: 10.1186/s12882-015-0030-8.

13.

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.

Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA.

Nephrol Dial Transplant. 2015 Aug;30(8):1336-44. doi: 10.1093/ndt/gfv034. Epub 2015 Mar 27.

14.

Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.

15.

Construction workers working in musculoskeletal pain and engaging in leisure-time physical activity: Findings from a mixed-methods pilot study.

Caban-Martinez AJ, Lowe KA, Herrick R, Kenwood C, Gagne JJ, Becker JF, Schneider SP, Dennerlein JT, Sorensen G.

Am J Ind Med. 2014 Jul;57(7):819-25. doi: 10.1002/ajim.22332. Epub 2014 Apr 23.

16.

Sustained perceptual invisibility of solid shapes following contour adaptation to partial outlines.

Cox MA, Lowe KA, Blake R, Maier A.

Conscious Cogn. 2014 May;26:37-50. doi: 10.1016/j.concog.2014.02.007. Epub 2014 Mar 20.

PMID:
24657633
17.

Value of symptom-triggered diagnostic evaluation for ovarian cancer.

Andersen MR, Lowe KA, Goff BA.

Obstet Gynecol. 2014 Jan;123(1):73-9. doi: 10.1097/AOG.0000000000000051.

18.
19.

CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.

Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2132-40. doi: 10.2215/CJN.04260413. Epub 2013 Sep 19.

20.

Characterization of soils from an industrial complex contaminated with elemental mercury.

Miller CL, Watson DB, Lester BP, Lowe KA, Pierce EM, Liang L.

Environ Res. 2013 Aug;125:20-9. doi: 10.1016/j.envres.2013.03.013. Epub 2013 Jun 27.

PMID:
23809204
21.

An international assessment of ovarian cancer incidence and mortality.

Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, Mohamed M, Mowat FS, Goff B.

Gynecol Oncol. 2013 Jul;130(1):107-14. doi: 10.1016/j.ygyno.2013.03.026. Epub 2013 Apr 2.

PMID:
23558050
22.

HDL-C Response Variability to Niacin ER in US Adults.

Christian JB, Olson EJ, Allen JK, Lowe KA.

Cholesterol. 2013;2013:681475. doi: 10.1155/2013/681475. Epub 2013 Feb 26.

23.

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA.

J Altern Complement Med. 2013 Aug;19(8):714-20. doi: 10.1089/acm.2012.0295. Epub 2013 Feb 27.

24.

Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms.

Lowe KA, Andersen MR, Kane JC, Robertson MD, Goff BA.

J Nurse Pract. 2013 Jan;9(1):28-33.

25.

Evaluation of epidemiology and animal data for risk assessment: chlorpyrifos developmental neurobehavioral outcomes.

Li AA, Lowe KA, McIntosh LJ, Mink PJ.

J Toxicol Environ Health B Crit Rev. 2012;15(2):109-84. doi: 10.1080/10937404.2012.645142. Review.

26.

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR.

Gynecol Oncol. 2012 Feb;124(2):230-5. doi: 10.1016/j.ygyno.2011.10.032. Epub 2011 Nov 6.

27.

Involvement in decision-making about treatment and ovarian cancer survivor quality of life.

Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA.

Gynecol Oncol. 2012 Mar;124(3):465-70. doi: 10.1016/j.ygyno.2011.10.029. Epub 2011 Oct 29.

28.

Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: National Health and Nutrition Examination Survey 2005-2008.

Christian JB, Bourgeois NE, Lowe KA.

J Cardiovasc Med (Hagerstown). 2011 Oct;12(10):714-22. doi: 10.2459/JCM.0b013e328349c4e5.

PMID:
21881447
29.

Prevalence, characteristics, and risk factors of elevated triglyceride levels in US children.

Christian JB, Juneja MX, Meadowcroft AM, Borden S, Lowe KA.

Clin Pediatr (Phila). 2011 Dec;50(12):1103-9. doi: 10.1177/0009922811414286. Epub 2011 Aug 3.

PMID:
21816828
30.

Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease.

Taras AR, Thorpe JD, Morris AD, Atwood M, Lowe KA, Beatty JD.

Am J Surg. 2011 May;201(5):605-10. doi: 10.1016/j.amjsurg.2011.01.017.

PMID:
21545907
31.

Meta-analysis of prospective studies of red meat consumption and colorectal cancer.

Alexander DD, Weed DL, Cushing CA, Lowe KA.

Eur J Cancer Prev. 2011 Jul;20(4):293-307. doi: 10.1097/CEJ.0b013e328345f985.

PMID:
21540747
32.

Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults.

Christian JB, Bourgeois N, Snipes R, Lowe KA.

Am J Cardiol. 2011 Mar 15;107(6):891-7. doi: 10.1016/j.amjcard.2010.11.008. Epub 2011 Jan 19.

PMID:
21247544
33.

Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies.

Alexander DD, Miller AJ, Cushing CA, Lowe KA.

Eur J Cancer Prev. 2010 Sep;19(5):328-41. doi: 10.1097/CEJ.0b013e32833b48fa. Review.

PMID:
20495462
34.

Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.

Taras AR, Hendrickson NA, Lowe KA, Atwood M, Beatty JD.

Am J Surg. 2010 May;199(5):625-8. doi: 10.1016/j.amjsurg.2010.01.009.

PMID:
20466106
35.

Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survival.

Precht LM, Lowe KA, Atwood M, Beatty JD.

Breast J. 2010 Jul-Aug;16(4):362-8. doi: 10.1111/j.1524-4741.2010.00935.x. Epub 2010 Apr 28.

PMID:
20443786
36.

Summary and meta-analysis of prospective studies of animal fat intake and breast cancer.

Alexander DD, Morimoto LM, Mink PJ, Lowe KA.

Nutr Res Rev. 2010 Jun;23(1):169-79. doi: 10.1017/S095442241000003X. Epub 2010 Feb 25. Review.

PMID:
20181297
37.

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban N.

Gynecol Oncol. 2010 Mar;116(3):378-83. doi: 10.1016/j.ygyno.2009.10.087. Epub 2009 Nov 28.

38.

Stressful life events and the tripartite model: relations to anxiety and depression in adolescent females.

Fox JK, Halpern LF, Ryan JL, Lowe KA.

J Adolesc. 2010 Feb;33(1):43-54. doi: 10.1016/j.adolescence.2009.05.009. Epub 2009 Jun 24.

PMID:
19556002
39.

Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.

Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban N, Henke M, Blau CA.

Stem Cells. 2009 Sep;27(9):2353-61. doi: 10.1002/stem.156.

40.

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Lowe KA, Andersen MR, Urban N, Paley P, Dresher CW, Goff BA.

Gynecol Oncol. 2009 Aug;114(2):225-30. doi: 10.1016/j.ygyno.2009.03.015. Epub 2009 May 7.

41.

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD, Urban N, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1365-72. doi: 10.1158/1055-9965.EPI-08-1034.

42.

Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.

Taras AR, Hendrickson NA, Pugliese MS, Lowe KA, Atwood M, Beatty JD.

Am J Surg. 2009 May;197(5):643-6; discussion 646-7. doi: 10.1016/j.amjsurg.2008.12.019.

PMID:
19393357
43.

Meta-analysis of animal fat or animal protein intake and colorectal cancer.

Alexander DD, Cushing CA, Lowe KA, Sceurman B, Roberts MA.

Am J Clin Nutr. 2009 May;89(5):1402-9. doi: 10.3945/ajcn.2008.26838. Epub 2009 Mar 4.

PMID:
19261724
44.

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh M, Andersen MR, Scholler N, Bergan L, Thorpe J, Urban N, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2480-7. doi: 10.1158/1055-9965.EPI-08-0150.

45.

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N.

Cancer. 2008 Aug 1;113(3):484-9. doi: 10.1002/cncr.23577.

46.

Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.

Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R, Anderson GL, Urban N.

Clin Cancer Res. 2008 May 1;14(9):2647-55. doi: 10.1158/1078-0432.CCR-07-1442.

47.

Computer-assisted mammography feedback program (CAMFP) an electronic tool for continuing medical education.

Urban N, Longton GM, Crowe AD, Drucker MJ, Lehman CD, Peacock S, Lowe KA, Zeliadt SB, Gaul MA.

Acad Radiol. 2007 Sep;14(9):1036-42.

48.

Association between body size and colorectal adenoma recurrence.

Jacobs ET, Martínez ME, Alberts DS, Jiang R, Lance P, Lowe KA, Thompson PA.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):982-90. Epub 2007 Jun 5.

49.

Changes in cancer worry associated with participation in ovarian cancer screening.

Andersen MR, Drescher CW, Zheng Y, Bowen DJ, Wilson S, Young A, McIntosh M, Mahony BS, Lowe KA, Urban N.

Psychooncology. 2007 Sep;16(9):814-20.

PMID:
17225260
50.

Identification, characterisation, and measurement of immunoglobulin concentrations in grey (Haliocherus grypus) and common (Phoca vitulina) seals.

King DP, Lowe KA, Hay AW, Evans SW.

Dev Comp Immunol. 1994 Sep-Oct;18(5):433-42. Erratum in: Dev Comp Immunol 1995 May-Jun;19(3):279-80.

PMID:
7535255

Supplemental Content

Support Center